Sector revisions AstraZeneca PLC

Equities

Market Closed - London S.E. Other stock markets 16:35:29 09/07/2025 BST			5-day change	1st Jan Change
10,362.00 ^GBX	+0.21%		-0.27%	-1.01%

06:46pm	Major deals involving U.S. drugmakers and biotechs over the past decade	RE
01:48pm	Berenberg Lifts AstraZeneca Price Target, Earnings Forecasts on Drug Pipeline Strength	MT

	Add to a list 0 selected To use this feature you must be a member Log in Sign up	1m. Revenue rev.	4m. EPS revision	4m. Revenue rev.	1y. EPS revision	1y. Revenue rev.	Visibility (Composite)	Nbr of analysts
	ASTRAZENECA PLC							20
	ELI LILLY AND COMPANY							27
	JOHNSON & JOHNSON							23
	ABBVIE INC.							27
	NOVO NORDISK A/S							22
	ROCHE HOLDING AG							20
	NOVARTIS AG							19
	MERCK & CO., INC.							24
	AMGEN INC.							28
	PFIZER, INC.							23
	GILEAD SCIENCES, INC.							26
	VERTEX PHARMACEUTICALS INCORPORATED							28
	SANOFI							23
	BRISTOL-MYERS SQUIBB COMPANY							22
	GSK PLC							19
	CHUGAI PHARMACEUTICAL CO., LTD.							14
	JIANGSU HENGRUI MEDICINE CO., LTD.							18
	TAKEDA PHARMACEUTICAL COMPANY LIMITED							16
	HALEON PLC							17
	Average							22
	Weighted average by Cap.							23